nevadensin has been researched along with hispidulin in 2 studies
| Studies (nevadensin) | Trials (nevadensin) | Recent Studies (post-2010) (nevadensin) | Studies (hispidulin) | Trials (hispidulin) | Recent Studies (post-2010) (hispidulin) |
|---|---|---|---|---|---|
| 40 | 0 | 25 | 123 | 0 | 76 |
| Protein | Taxonomy | nevadensin (IC50) | hispidulin (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 0.8337 | |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | 2.71 | |
| Dipeptidyl peptidase 4 | Sus scrofa (pig) | 0.49 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.3533 | |
| MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | 1.205 | |
| MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | 0.252 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beutler, JA; Boyd, MR; Cardellina, JH; Haemers, A; Hamel, E; Rajan, P; Roitman, JN; Vlietinck, AJ | 1 |
| Goettert, M; Koch, P; Laufer, S; Merfort, I; Schattel, V | 1 |
2 other study(ies) available for nevadensin and hispidulin
| Article | Year |
|---|---|
Structure-activity requirements for flavone cytotoxicity and binding to tubulin.
Topics: Antineoplastic Agents, Phytogenic; Biopolymers; Cell Survival; Colchicine; Drug Screening Assays, Antitumor; Flavonoids; Humans; Protein Binding; Structure-Activity Relationship; Tubulin; Tumor Cells, Cultured | 1998 |
Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.
Topics: Animals; Flavonoids; Humans; Mitogen-Activated Protein Kinase 10; Mitogen-Activated Protein Kinase 14; Models, Molecular; Protein Kinase Inhibitors; Structure-Activity Relationship | 2010 |